NasdaqGS - Delayed Quote • USD
Integra LifeSciences Holdings Corporation (IART)
At close: 4:00 PM EDT
After hours: 4:01 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 12 | 12 | 13 | 13 |
| Avg. Estimate | 0.55 | 0.75 | 3.19 | 3.61 |
| Low Estimate | 0.53 | 0.67 | 3.16 | 3.48 |
| High Estimate | 0.58 | 0.84 | 3.21 | 3.73 |
| Year Ago EPS | 0.74 | 0.71 | 3.1 | 3.19 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 11 | 11 | 12 | 12 |
| Avg. Estimate | 361.96M | 395.8M | 1.62B | 1.71B |
| Low Estimate | 360.4M | 382M | 1.6B | 1.67B |
| High Estimate | 363M | 407.6M | 1.67B | 1.84B |
| Year Ago Sales | 380.85M | 374.07M | 1.54B | 1.62B |
| Sales Growth (year/est) | -5.00% | 5.80% | 4.90% | 5.90% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | 0.74 | 0.57 | 0.78 | 0.9 |
| EPS Actual | 0.74 | 0.71 | 0.76 | 0.89 |
| Difference | 0 | 0.14 | -0.02 | -0.01 |
| Surprise % | 0.00% | 24.60% | -2.60% | -1.10% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0.55 | 0.75 | 3.19 | 3.61 |
| 7 Days Ago | 0.55 | 0.75 | 3.19 | 3.61 |
| 30 Days Ago | 0.55 | 0.74 | 3.19 | 3.62 |
| 60 Days Ago | 0.74 | 0.81 | 3.44 | 3.81 |
| 90 Days Ago | 0.74 | 0.81 | 3.44 | 3.81 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | IART | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -25.70% | -- | -- | 6.50% |
| Next Qtr. | 5.60% | -- | -- | 12.00% |
| Current Year | 2.90% | -- | -- | 5.30% |
| Next Year | 13.20% | -- | -- | 13.10% |
| Next 5 Years (per annum) | 8.80% | -- | -- | 11.09% |
| Past 5 Years (per annum) | 7.23% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Upgrade | Citigroup: Sell to Neutral | 4/3/2024 |
| Maintains | Truist Securities: Hold to Hold | 3/1/2024 |
| Maintains | JMP Securities: Market Outperform to Market Outperform | 2/29/2024 |
| Maintains | Truist Securities: Hold to Hold | 12/22/2023 |
| Maintains | Truist Securities: Hold to Hold | 12/14/2023 |
| Reiterates | JMP Securities: Market Outperform to Market Outperform | 12/14/2023 |
Related Tickers
CNMD CONMED Corporation
65.78
+6.27%
NARI Inari Medical, Inc.
38.42
+0.92%
ITGR Integer Holdings Corporation
109.58
-1.41%
QDEL QuidelOrtho Corporation
39.64
-0.13%
PODD Insulet Corporation
166.19
+1.23%
INSP Inspire Medical Systems, Inc.
237.45
+2.79%
EW Edwards Lifesciences Corporation
86.43
-1.80%
NVRO Nevro Corp.
11.32
-2.58%
LIVN LivaNova PLC
55.53
+0.78%
BRKR Bruker Corporation
80.97
+0.47%